Company / Working Capital per Share
Repligen Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$17707.59
FY2025
5-year range
$9716.66 / $17707.59
FY2021-FY2025
Trend
+5.5%
vs FY2024
Sector context
#1 of 210
Health Care
What the data says
Among 210 Health Care companies, Repligen is in the top 0% for working capital per share. Working Capital per Share has increased for 4 consecutive years, from $9716.66 in FY2021 to $17707.59 in FY2025.
Based on SEC 10-K filings.
17707.59 in FY2025 with a 5-year CAGR of +10.3%. Ranks 1st among 210 companies in Health Care.
Improved from $16787.06 to $17707.59 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +19.7%
- 5-Year CAGR
- +10.3%
- 10-Year CAGR
- -
Sector benchmark
+14830.6% above sector average
Key checks
Key Insights
- Repligen's working capital per share has grown for 4 consecutive years.
- In FY2025, working capital per share increased 5.5% year-over-year.
- Ranks #1 out of 210 companies in the Health Care sector.
- Lowest working capital per share in the period was in FY2018.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17707.59 | +5.5% |
| FY2024 | $16791.28 | +0.0% |
| FY2023 | $16787.06 | +62.4% |
| FY2022 | $10337.17 | +6.4% |
| FY2021 | $9716.66 | -10.2% |
| FY2020 | $10825.84 | +89652.8% |
| FY2019 | $12.06 | +275.9% |
| FY2018 | $3.21 | -50.1% |
| FY2017 | $6.43 | +29.9% |
| FY2016 | $4.95 | +92.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026